|
Volumn 40, Issue 8, 2002, Pages 62-64
|
▼Seretide and ▼Symbicort in asthma management
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
BUDESONIDE;
BUDESONIDE PLUS FORMOTEROL;
CHLOROFLUOROCARBON;
CORTICOSTEROID;
FLUTICASONE PROPIONATE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
FORMOTEROL;
LONG ACTING DRUG;
PLACEBO;
SALMETEROL;
SALMETEROL XINAFOATE;
ADOLESCENT;
ADULT;
ARTICLE;
ASTHMA;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG COST;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
HEADACHE;
HEART PALPITATION;
HUMAN;
LICENCE;
MAJOR CLINICAL STUDY;
METERED DOSE INHALER;
PATIENT CARE;
SUPERINFECTION;
TREATMENT FAILURE;
TREMOR;
UNITED KINGDOM;
|
EID: 0036678607
PISSN: 00126543
EISSN: None
Source Type: Journal
DOI: 10.1136/dtb.2002.40862 Document Type: Article |
Times cited : (2)
|
References (16)
|